ES2330291B1 - Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. - Google Patents

Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.

Info

Publication number
ES2330291B1
ES2330291B1 ES200800597A ES200800597A ES2330291B1 ES 2330291 B1 ES2330291 B1 ES 2330291B1 ES 200800597 A ES200800597 A ES 200800597A ES 200800597 A ES200800597 A ES 200800597A ES 2330291 B1 ES2330291 B1 ES 2330291B1
Authority
ES
Spain
Prior art keywords
mucosas
cosmetic
skin
treatment
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200800597A
Other languages
English (en)
Other versions
ES2330291A1 (es
Inventor
Sanz Nuria Garcia
Den Nest Wim Van
Serraima Cristina Carreno
Montiel Antonio Ferrer
Puche Juan Cebrian
Domenech Nuria Alminana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipotec SA
Original Assignee
Lipotec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200800597A priority Critical patent/ES2330291B1/es
Application filed by Lipotec SA filed Critical Lipotec SA
Priority to BRPI0906064A priority patent/BRPI0906064B8/pt
Priority to US12/920,241 priority patent/US9315564B2/en
Priority to PCT/EP2009/001419 priority patent/WO2009106343A1/en
Priority to DK09715427.2T priority patent/DK2254908T3/da
Priority to EP09715427A priority patent/EP2254908B1/en
Priority to ES09715427T priority patent/ES2399581T3/es
Priority to CN200980114319.4A priority patent/CN102015764B/zh
Priority to PT97154272T priority patent/PT2254908E/pt
Priority to AU2009218680A priority patent/AU2009218680B2/en
Priority to JP2010548031A priority patent/JP5613062B2/ja
Priority to MX2010009485A priority patent/MX2010009485A/es
Priority to CA2716650A priority patent/CA2716650A1/en
Priority to PL09715427T priority patent/PL2254908T3/pl
Priority to SI200930509T priority patent/SI2254908T1/sl
Priority to KR1020107021674A priority patent/KR101656533B1/ko
Priority to HK11105363.5A priority patent/HK1151301B/en
Publication of ES2330291A1 publication Critical patent/ES2330291A1/es
Priority to IL207808A priority patent/IL207808A/en
Priority to ZA2010/06889A priority patent/ZA201006889B/en
Application granted granted Critical
Publication of ES2330291B1 publication Critical patent/ES2330291B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
ES200800597A 2008-02-29 2008-02-29 Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. Expired - Fee Related ES2330291B1 (es)

Priority Applications (19)

Application Number Priority Date Filing Date Title
ES200800597A ES2330291B1 (es) 2008-02-29 2008-02-29 Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
MX2010009485A MX2010009485A (es) 2008-02-29 2009-02-27 Composiciones farmaceuticas o cosmeticas que comprenden inhibidores de metaloproteinasa.
PCT/EP2009/001419 WO2009106343A1 (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
DK09715427.2T DK2254908T3 (da) 2008-02-29 2009-02-27 Kosmetiske eller farmaceutiske sammensætninger omfattende metalloproteinasehæmmere
EP09715427A EP2254908B1 (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
ES09715427T ES2399581T3 (es) 2008-02-29 2009-02-27 Composiciones cosméticas o farmacéuticas que comprenden inhibidores de metaloproteinasa
CN200980114319.4A CN102015764B (zh) 2008-02-29 2009-02-27 包含金属蛋白酶抑制剂的化妆品组合物或药物组合物
PL09715427T PL2254908T3 (pl) 2008-02-29 2009-02-27 Kosmetyczne lub farmaceutyczne kompozycje obejmujące inhibitory metaloproteinaz
US12/920,241 US9315564B2 (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
JP2010548031A JP5613062B2 (ja) 2008-02-29 2009-02-27 メタロプロテイナーゼ阻害剤を含む化粧品または医薬組成物
BRPI0906064A BRPI0906064B8 (pt) 2008-02-29 2009-02-27 peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i)
AU2009218680A AU2009218680B2 (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
PT97154272T PT2254908E (pt) 2008-02-29 2009-02-27 Peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i)
SI200930509T SI2254908T1 (sl) 2008-02-29 2009-02-27 Kozmetični ali farmacevtski sestavki, ki vsebujejo metaloprotenazne inhibitorje
KR1020107021674A KR101656533B1 (ko) 2008-02-29 2009-02-27 금속단백분해효소 억제제를 포함하는 화장품 또는 약학적 조성물
HK11105363.5A HK1151301B (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
CA2716650A CA2716650A1 (en) 2008-02-29 2009-02-27 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors
IL207808A IL207808A (en) 2008-02-29 2010-08-26 Pharmaceutical and cosmetic preparations containing metalloproteinase inhibitors
ZA2010/06889A ZA201006889B (en) 2008-02-29 2010-09-28 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200800597A ES2330291B1 (es) 2008-02-29 2008-02-29 Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.

Publications (2)

Publication Number Publication Date
ES2330291A1 ES2330291A1 (es) 2009-12-07
ES2330291B1 true ES2330291B1 (es) 2010-10-18

Family

ID=40674197

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200800597A Expired - Fee Related ES2330291B1 (es) 2008-02-29 2008-02-29 Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
ES09715427T Active ES2399581T3 (es) 2008-02-29 2009-02-27 Composiciones cosméticas o farmacéuticas que comprenden inhibidores de metaloproteinasa

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES09715427T Active ES2399581T3 (es) 2008-02-29 2009-02-27 Composiciones cosméticas o farmacéuticas que comprenden inhibidores de metaloproteinasa

Country Status (17)

Country Link
US (1) US9315564B2 (es)
EP (1) EP2254908B1 (es)
JP (1) JP5613062B2 (es)
KR (1) KR101656533B1 (es)
CN (1) CN102015764B (es)
AU (1) AU2009218680B2 (es)
BR (1) BRPI0906064B8 (es)
CA (1) CA2716650A1 (es)
DK (1) DK2254908T3 (es)
ES (2) ES2330291B1 (es)
IL (1) IL207808A (es)
MX (1) MX2010009485A (es)
PL (1) PL2254908T3 (es)
PT (1) PT2254908E (es)
SI (1) SI2254908T1 (es)
WO (1) WO2009106343A1 (es)
ZA (1) ZA201006889B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012152966A1 (es) * 2011-05-11 2012-11-15 Laboratorios Starga, S.L Composición cosmética para el cuidado de la cuperosis

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050069566A1 (en) * 2003-08-04 2005-03-31 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) * 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
CN1856294A (zh) * 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
JP2010502690A (ja) * 2006-09-08 2010-01-28 フォーミックス エルティーディー． 有色または着色可能発泡性組成物
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
ES2330291B1 (es) * 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
ES2336995B1 (es) * 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
FR2956115B1 (fr) 2010-02-05 2012-04-06 Isp Investments Inc Nouveaux peptides activateurs de la caspase-14 et compositions les comprenant
US20110280850A1 (en) * 2010-05-12 2011-11-17 Starr Elizabeth I Compositions Containing DNA Repair Enzyme And Anogeissus Extract
US10758630B2 (en) 2010-08-13 2020-09-01 The Johns Hopkins University Topical compositions and methods of detection and treatment
US20120237494A1 (en) * 2010-09-30 2012-09-20 Daly Susan M Compositions Containing Zinc PCA And Anogeissus Extract
ES2397890B1 (es) * 2011-03-25 2014-02-07 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas.
US9480864B2 (en) 2011-08-17 2016-11-01 Basf Corporation Marine based cosmetic active ingredients and use thereof
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도
CN104254339B (zh) * 2012-04-16 2020-01-21 路博润高级材料公司 用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途
KR101437237B1 (ko) * 2012-12-10 2014-10-30 미원상사주식회사 피부노화 방지용 테트라펩타이드 및 이를 함유하는 화장료 조성물
ES2624961T3 (es) 2013-03-21 2017-07-18 Sanofi-Aventis Deutschland Gmbh Síntesis de productos de péptido que contienen imida cíclica
ES2623979T3 (es) 2013-03-21 2017-07-12 Sanofi-Aventis Deutschland Gmbh Síntesis de productos peptídicos que contienen hidantoína
TWI768228B (zh) * 2014-04-18 2022-06-21 葛列戈里 P 派倫 用於皮膚保養之局部投與方法及組合物
FR3023164B1 (fr) * 2014-07-03 2017-10-20 Expanscience Lab Extraits peptidiques de lupin et fermete de la peau
KR102481341B1 (ko) 2014-10-31 2022-12-23 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 피부 표면으로 활성 작용제의 전달을 위한 열가소성 폴리우레탄 필름
KR101744959B1 (ko) * 2014-12-05 2017-06-12 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
CA3003871A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
KR102863391B1 (ko) 2016-02-04 2025-09-22 앨러스틴 스킨케어, 인크. 침습 및 비침습 시술적 피부 관리를 위한 조성물 및 방법
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11266344B2 (en) 2016-09-21 2022-03-08 Samsung Electronics Co., Ltd. Method for measuring skin condition and electronic device therefor
US12410143B2 (en) 2017-01-17 2025-09-09 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase
US10493011B2 (en) 2017-08-03 2019-12-03 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
KR102311724B1 (ko) 2017-09-15 2021-10-13 (주)아모레퍼시픽 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
KR102395984B1 (ko) 2017-09-27 2022-05-11 (주)아모레퍼시픽 슈도알터로모나스 카라기노보라의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물
CN107898658A (zh) * 2017-12-13 2018-04-13 南昌师范学院 六胜肽祛皱增效原液组合物
KR102111025B1 (ko) * 2018-06-05 2020-05-15 고려대학교 산학협력단 신경줄기세포 배양액을 유효성분으로 함유하는 항노화 또는 주름억제용 화장료 조성물 및 이의 제조 방법
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
CN109010113B (zh) * 2018-08-28 2021-08-17 高宝化妆品（中国）有限公司 一种修复敏感肌肤的组合物及其应用
EP4215178A1 (en) * 2020-09-11 2023-07-26 Chemyunion Ltda Composition, use of the composition, cosmetic method and method for modulating the production of sebum
WO2022157548A1 (en) 2021-01-24 2022-07-28 Forrest Michael David Inhibitors of atp synthase - cosmetic and therapeutic uses
CN118852347A (zh) * 2021-09-09 2024-10-29 禾美生物科技(浙江)有限公司 具有抗衰修护功效的功能多肽及其应用
WO2024092332A1 (pt) * 2022-10-31 2024-05-10 Chemyunion Ltda Compostos e composições farmacêuticas, dermatológicas ou cosméticas para redução da síntese de melanina, estimulação da produção de colágeno tipo i, despigmentação da pele e/ou promover uma ação antienvelhecimento da pele em um indivíduo ou animal, usos e métodos
WO2024229256A1 (en) * 2023-05-03 2024-11-07 Glo Pharma, Inc. Methods and compositions for cosmetic applications

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69716449T2 (de) 1996-08-28 2003-08-07 The Procter & Gamble Company, Cincinnati Substituierte zyklische amine als metalloproteaseinhibitoren
JP2002515898A (ja) 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
ATE375387T1 (de) * 1997-06-25 2007-10-15 Novozymes As Modifiziertes polypeptid
FR2778558B1 (fr) 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
US7094754B2 (en) * 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) * 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
WO2004033668A2 (en) 2002-10-10 2004-04-22 Diversa Corporation Proteases, nucleic acids encoding them and methods for making and using them
CN1314704C (zh) * 2002-11-20 2007-05-09 中国人民解放军军事医学科学院放射与辐射医学研究所 基质金属蛋白酶2的小肽抑制剂
ES2330291B1 (es) * 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012152966A1 (es) * 2011-05-11 2012-11-15 Laboratorios Starga, S.L Composición cosmética para el cuidado de la cuperosis
ES2392283A1 (es) * 2011-05-11 2012-12-07 Laboratorios Starga S.L. Composicion cosmetica para el cuidado de la cuperosis mejorada.

Also Published As

Publication number Publication date
US9315564B2 (en) 2016-04-19
DK2254908T3 (da) 2013-03-04
KR101656533B1 (ko) 2016-09-09
PL2254908T3 (pl) 2013-04-30
PT2254908E (pt) 2013-01-25
AU2009218680B2 (en) 2013-11-21
CA2716650A1 (en) 2009-09-03
EP2254908A1 (en) 2010-12-01
MX2010009485A (es) 2011-02-15
ES2399581T3 (es) 2013-04-02
JP5613062B2 (ja) 2014-10-22
ES2330291A1 (es) 2009-12-07
KR20120058371A (ko) 2012-06-07
BRPI0906064B1 (pt) 2020-04-14
IL207808A0 (en) 2010-12-30
CN102015764A (zh) 2011-04-13
CN102015764B (zh) 2014-10-29
BRPI0906064A2 (pt) 2015-06-30
EP2254908B1 (en) 2012-11-21
US20110002969A1 (en) 2011-01-06
JP2011514891A (ja) 2011-05-12
AU2009218680A1 (en) 2009-09-03
WO2009106343A1 (en) 2009-09-03
SI2254908T1 (sl) 2013-06-28
IL207808A (en) 2014-02-27
ZA201006889B (en) 2011-05-25
HK1151301A1 (en) 2012-01-27
BRPI0906064B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
ES2330291B1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
ZA201202705B (en) Peptides used in the treatment and/or care of the skin.mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
IL214462A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
CO6791607A2 (es) Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
IL215503A0 (en) Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
BRPI0722043A2 (pt) composições de clareamento de pele cosmética tópicas e métodos de uso das mesmas.
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
PL2065029T3 (pl) Kompozycja do higieny osobistej i kosmetyczna, zawierająca tetrapeptydy z motywami GX1X2G, PX1X2P lub PX1X2K
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
BRPI0813897A2 (pt) Uso de uma substância, composição cosmética ou dermo-cosmética ou neutracêutica, composição farmacêutica, método de cuidado cosmético, e, seqüência de nucleotídeos.
PL2928484T3 (pl) Związki przydatne w leczeniu lub pielęgnacji skóry, włosów lub błon śluzowych oraz ich kompozycji kosmetycznych lub farmaceutycznych
BRPI1006974A2 (pt) "uso de absorvedores de uv, e, composição cosmética."
BRPI0819361A2 (pt) Composição de tratamento de cabelos e agente de tratamento
WO2009044279A3 (en) Peptides having antimicrobial and/or biosurfactant properties
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
FR2961814B1 (fr) Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
BRPI1012263A2 (pt) complexo clarificante de pele, uso do referido complexo, composição cosmética ou farmacêutica compreendendo o referido complexo e método de aplicação do mesmo.
CL2007003190A1 (es) Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras.
BR112013003030A2 (pt) ''composição cosmética, método para o tratamento cosmético não terapêutico das substâncias queratínas e uso de uma composição''
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
FI20060729A0 (fi) Ihon- tai karvanhoitokoostumus tai sen valmistuksessa käytetty puolivalmiste
WO2007100874A3 (en) Compositions containing peptides with non-natural amino acids and methods of use
WO2007108883A3 (en) High-deposition compositions and uses thereof
BRPI0905927A2 (pt) "composto, composição cosmética, comsposição farmacêutica, uso e processo de tratamento cosmético das matérias queratínicas"

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20091207

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2330291B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180924